JP1518090S - - Google Patents
Info
- Publication number
- JP1518090S JP1518090S JPD2014-2683F JP2014002683F JP1518090S JP 1518090 S JP1518090 S JP 1518090S JP 2014002683 F JP2014002683 F JP 2014002683F JP 1518090 S JP1518090 S JP 1518090S
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2014-2683F JP1518090S (enExample) | 2013-04-22 | 2013-04-22 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2014-2683F JP1518090S (enExample) | 2013-04-22 | 2013-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP1518090S true JP1518090S (enExample) | 2015-02-23 |
Family
ID=53480151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JPD2014-2683F Active JP1518090S (enExample) | 2013-04-22 | 2013-04-22 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP1518090S (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD963195S1 (en) * | 2019-09-26 | 2022-09-06 | Okamura Corporation | Office booth |
| USD965819S1 (en) * | 2019-09-26 | 2022-10-04 | Okamura Corporation | Office booth |
-
2013
- 2013-04-22 JP JPD2014-2683F patent/JP1518090S/ja active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD963195S1 (en) * | 2019-09-26 | 2022-09-06 | Okamura Corporation | Office booth |
| USD965819S1 (en) * | 2019-09-26 | 2022-10-04 | Okamura Corporation | Office booth |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR134186A2 (es) | Un anticuerpo anti-csf-1r, un proceso para producirlo, una composición farmacéutica que lo comprende, una secuencia de adn aislado, un vector de expresión o clonación y una célula hospedadora | |
| BR112015007533A2 (enExample) | ||
| BR112014017733A2 (enExample) | ||
| BR112014018502A2 (enExample) | ||
| BR112014017739A2 (enExample) | ||
| BR112014019326A2 (enExample) | ||
| BR112014018516A2 (enExample) | ||
| BR112014018480A2 (enExample) | ||
| BR112014020341A2 (enExample) | ||
| BR112014017855A2 (enExample) | ||
| BR112014017765A2 (enExample) | ||
| BR112016007944A2 (enExample) | ||
| BR112014021878A2 (enExample) | ||
| BR112016013398A2 (enExample) | ||
| BR112016009522A2 (enExample) | ||
| BR112014018468A2 (enExample) | ||
| BR112014017901A2 (enExample) | ||
| BR112014019204A2 (enExample) | ||
| BR112014018207A2 (enExample) | ||
| BR112014017722A2 (enExample) | ||
| BR112016009081A2 (enExample) | ||
| BR112014017653A2 (enExample) | ||
| BR112014018578A2 (enExample) | ||
| BR112014018483A2 (enExample) | ||
| BR112014017794A2 (enExample) |